TEVA:NYE-Teva Pharma Industries Ltd ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 21.68

Change

-0.26 (-1.19)%

Market Cap

N/A

Volume

7.20M

Analyst Target

USD 12.19
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+2.20 (+1.32%)

USD 74.37B
HLN Haleon plc

+0.08 (+0.88%)

USD 42.79B
TAK Takeda Pharmaceutical Co Ltd A..

-0.05 (-0.38%)

USD 41.33B
RDY Dr. Reddy’s Laboratories Ltd..

-0.49 (-3.20%)

USD 13.11B
ELAN Elanco Animal Health

+0.16 (+1.35%)

USD 5.65B
AMRX Amneal Pharmaceuticals, Inc. C..

+0.09 (+1.09%)

USD 3.68B
BHC Bausch Health Companies Inc

+0.08 (+1.06%)

USD 2.91B
CPHI China Pharma Holdings Inc

N/A

USD 3.69M
YCBD cbdMD Inc

+0.06 (+10.87%)

USD 1.96M
EBS Emergent Biosolutions Inc

+0.45 (+4.73%)

N/A

ETFs Containing TEVA

FLWR:SW 5.80 % 0.00 %

N/A

N/A
THNR Amplify ETF Trust 4.81 % 0.00 %

+0.03 (+0.12%)

USD 4.08M
IDVO Amplify International Enh.. 3.56 % 0.00 %

+0.01 (+0.12%)

USD 0.15B
ALFI 0.00 % 0.88 %

N/A

N/A
EIS iShares MSCI Israel ETF 0.00 % 0.59 %

+0.32 (+0.12%)

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
GVIP Goldman Sachs Hedge Indus.. 0.00 % 0.45 %

+0.70 (+0.12%)

USD 0.32B
GWL 0.00 % 0.34 %

N/A

N/A
BOUT Innovator ETFs Trust - In.. 0.00 % 0.80 %

+0.50 (+0.12%)

USD 0.01B
ISRPF iShares Public Limited Co.. 0.00 % 0.00 %

N/A

USD 2.22B
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
IS3T:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRCF iShares V Public Limited .. 0.00 % 0.00 %

+0.10 (+0.12%)

N/A
ISRHF iShares V Public Limited .. 0.00 % 0.00 %

N/A

N/A
ISRUF iShares V Public Limited .. 0.00 % 0.00 %

+0.63 (+0.12%)

N/A
ISRZF iShares II Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRIF 0.00 % 0.00 %

N/A

N/A
ISRVF iShares Public Limited Co.. 0.00 % 0.00 %

-0.52 (0.12%)

N/A
ISRWF 0.00 % 0.00 %

N/A

N/A
ISRNF 0.00 % 0.00 %

N/A

N/A
ISRRF 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.63% 43% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.63% 43% F 16% F
Trailing 12 Months  
Capital Gain 97.27% 93% A 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.27% 93% A 97% N/A
Trailing 5 Years  
Capital Gain 112.55% 100% F 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 112.55% 100% F 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 11.95% 73% C 69% C-
Dividend Return 11.95% 67% D+ 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 42.24% 53% F 23% F
Risk Adjusted Return 28.28% 60% D- 42% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector